AdvanSix Inc.

Good morning and welcome to the Advance 6 Fourth Quarter 2022 Earnings Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing star then zero on your telephone keypad. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then 1 on your telephone keypad. To withdraw your question, please press star then 2. Please note this event is being recorded. I would now like to turn the conference over to Adam Kressel, VP Investor Relations and Treasurer. Please go ahead.

Thank you, Andrew. Good morning and welcome to Advancix's fourth quarter 2022 earnings conference call. With me here today are President and CEO Aaron Kane and Senior Vice President and CFO Michael Preston. This call and webcast, including any non-GAAP reconciliations, are available on our website at investors.advancix.com. Note that elements of this presentation contain forward-looking statements that are based on our best view of the world and of our business as we see it today. Those elements can change, and the actual results could differ materially from those projected, and we ask that you consider them in that light. We refer you to the forward-looking statements included in our press release and earnings presentation. In addition, we identify the principal risks and uncertainties that affect our performance in our SEC filings, including our annual report on Form 10-K, as further updated in subsequent filings with the SEC. This morning, we will review our financial results for the fourth quarter and full year 2022 and share our outlook for our key product lines and end markets. Finally, we'll leave time for your questions at the end. So with that, I'll turn the call over to AdvanceX's president and CEO, Erin Kane.

Thanks, Adam, and good morning, everyone. Thank you for joining us and for your continued interest in AdvanceX. As you saw in our press release, Advancix delivered record annual sales, earnings, and cashflow performance in 2022, reflecting strong commercial execution. This builds on our track record of performance with earnings growth for the third consecutive year. Now let me share a few highlights before Mike covers the details of our financials in a moment. We continue to benefit from our diversified portfolio, an integrated, efficient, and cost-advantaged business model. In the fourth quarter, our strong commercial performance helped to offset pockets of soft-end market demand, customer destocking, and operational challenges. Cash flow generation continued to be robust to close out the year, supporting disciplined and value-creative capital deployment. In 2022, we enhanced our capital deployment with the acquisition of U.S. Amines and an increase in return of cash to shareholders through share repurchases and an increased dividend while further reducing debt. Our board of directors has approved an additional $75 million share repurchase authorization, reinforcing the flexibility we've built into our capital allocation strategy. We've also had several exciting recognitions recently. I am pleased to announce that we continue to be recognized for our strong corporate governance and focus on sustainability. Advantix was recently awarded its second consecutive platinum rating for corporate social responsibility from Echovatus. This continues to rank us among the top 1% of all companies assessed. In addition, the National Association of Corporate Directors New Jersey chapter has recognized Advantix as a public company board of the year. Leading with transparency and accountability enables us to deliver better results for our stakeholders while driving our long-term strategies forward. Now, looking to 2023, we believe that we are well-positioned for another year of differentiated performance, supported by a diverse product portfolio, continued strong agricultural and fertilizer industry fundamentals, and the resilience of our business model. Roughly one-third of our portfolio is in the agricultural sector, including ag chemicals, and our position in this attractive market has extended even further through our acquisitions of U.S. Amines, as well as the packaged ammonium sulfate business CIS, and organic investments to expand our high-value granular ammonium sulfate. While we do anticipate the challenges of an uncertain environment and expect demand weakness in several market segments within our nylon and chemical intermediate product lines, we remain confident in our demonstrated ability to execute and perform through various macroeconomic cycles. We have structurally improved the earnings power of this business, and our competitive advantage will support us running disproportionately higher plant production rates in 2023 to complement our strong commercial performance. Our healthy balance sheet will also serve us well and continues to support our ability to deploy capital and maximize shareholder value. With that, I'll turn it over to Mike to discuss the financial.